These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10463275)

  • 21. Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group.
    Ritchey ML; Shamberger RC; Haase G; Horwitz J; Bergemann T; Breslow NE
    J Am Coll Surg; 2001 Jan; 192(1):63-8; quiz 146. PubMed ID: 11192924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephroblastoma in experience of pediatrics clinic from Cluj-Napoca between 1974-1997--a clinical and anatomopathological approach.
    Ples R
    Folia Med (Plovdiv); 1998; 40(3B Suppl 3):106-8. PubMed ID: 10206007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.
    Grundy P; Breslow N; Green DM; Sharples K; Evans A; D'Angio GJ
    J Clin Oncol; 1989 May; 7(5):638-47. PubMed ID: 2540289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic nephrogenic rest.
    Argani P; Collins MH
    Am J Surg Pathol; 2006 Oct; 30(10):1339-41. PubMed ID: 17001170
    [No Abstract]   [Full Text] [Related]  

  • 26. [Wilms' tumor: reached progress and future prospects].
    Tamaro P
    Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.
    Vujanić GM; Schiavo Lena M; Sebire NJ
    Virchows Arch; 2019 Feb; 474(2):227-234. PubMed ID: 30515564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.
    Green DM; Thomas PR; Shochat S
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1267-74. PubMed ID: 8591964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological variations among cases of Wilms' tumor in Bangladesh and its relationship with prognosis.
    Ara T; Khan WA; Ali SM
    Bangladesh Med Res Counc Bull; 1997 Aug; 23(2):56-9. PubMed ID: 9465437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephroblastic neoplasms.
    Khoury JD
    Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
    Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
    Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New developments in the pathology of Wilms tumor.
    Beckwith JB
    Cancer Invest; 1997; 15(2):153-62. PubMed ID: 9095211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment strategy for children with Wilms tumor].
    Fukuzawa M
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
    Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
    J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective validation of a new staging system for Wilms' tumor.
    Farewell VT; D'Angio GJ; Breslow N; Norkool P
    Cancer Clin Trials; 1981; 4(2):167-71. PubMed ID: 6265112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of hepatic adhesion, invasion, and metastases at diagnosis of Wilms' tumor. The National Wilms' Tumor Study Group.
    Thomas PR; Shochat SJ; Norkool P; Beckwith JB; Breslow NE; D'Angio GJ
    Cancer; 1991 Dec; 68(11):2486-8. PubMed ID: 1657359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3.
    Ritchey ML; Pringle KC; Breslow NE; Takashima J; Moksness J; Zuppan CW; Beckwith JB; Thomas PR; Kelalis PP
    Ann Surg; 1994 Nov; 220(5):683-90. PubMed ID: 7979618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms tumour with unfavourable histology: implications for clinicians in the Third World.
    Hadley GP; Govender D; Landers G
    Med Pediatr Oncol; 2001 Jun; 36(6):652-3. PubMed ID: 11344499
    [No Abstract]   [Full Text] [Related]  

  • 39. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.